|
The buzz: A healthier future. On Pharma and Technology Part 1, we discussed the need for pharma to move quickly to introduce safe, cost-effective drugs that respond to cancer, Ebola, and other chronic and urgent diseases. Now we’ll explore how pharma and medical devices companies are working to surmount health market hurdles andprepare for a healthier global future. How soon can they glean life-saving insights by connecting the dots scientific, clinical, genomic, and patient therapy data? Will new collaboration networks add value to clinical trials and post-drug-launches? Are they optimistic?
|
